US Stock MarketDetailed Quotes

QNCX Quince Therapeutics

Watchlist

0.850
+0.018+2.13%

Trading May 31 11:59 ET

36.73MMarket Cap-1118P/E (TTM)

Quince Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-134.04%-8.35M

58.46%-18.29M

-4.16%-6.08M

28.06%-4.82M

75.17%-3.83M

77.82%-3.57M

30.02%-44.04M

59.53%-5.84M

61.38%-6.7M

12.23%-15.42M

Net income from continuing operations

9.02%-11.15M

39.25%-31.39M

-60.72%-8.89M

32.45%-5.35M

70.50%-4.89M

43.38%-12.25M

42.56%-51.66M

76.35%-5.53M

63.51%-7.92M

23.86%-16.56M

Operating gains losses

----

-143.62%-41K

-300.00%-34K

---8K

---2K

--3K

--94K

--17K

--0

----

Depreciation and amortization

135.29%40K

57.84%322K

623.81%304K

--0

-98.81%1K

-55.26%17K

-40.70%204K

-50.00%42K

-54.02%40K

-3.45%84K

Deferred tax

----

---284K

Other non cash items

1,282.66%2.93M

632.91%1.67M

6,706.90%1.92M

----

---248K

-257.29%-313K

---29K

----

Change In working capital

-150.16%-805K

120.11%1.98M

114.15%250K

71.89%-79K

105.13%201K

141.55%1.61M

-130.67%-9.83M

-961.95%-1.77M

92.17%-281K

-31.43%-3.92M

-Change in prepaid assets

-131.14%-440K

64.57%4.25M

972.83%1.97M

-168.58%-443K

-23.77%1.3M

3,264.29%1.41M

411.22%2.58M

27.78%184K

-26.42%646K

156.13%1.71M

-Change in payables and accrued expense

-235.86%-322K

82.07%-2.26M

22.69%-1.52M

131.20%298K

77.32%-1.27M

105.82%237K

-284.59%-12.6M

-3,277.42%-1.97M

78.39%-955K

-3,438.10%-5.61M

-Change in other current assets

---8K

-104.64%-9K

-147.37%-9K

--0

225.16%194K

2,000.00%19K

158.33%28K

83.02%-18K

-Change in other working capital

22.22%-35K

----

--66K

--171K

---45K

----

Cash from discontinued investing activities

Operating cash flow

-134.04%-8.35M

58.46%-18.29M

-4.16%-6.08M

28.06%-4.82M

75.17%-3.83M

77.82%-3.57M

30.02%-44.04M

59.53%-5.84M

61.38%-6.7M

12.23%-15.42M

Investing cash flow

Cash flow from continuing investing activities

60.90%8.91M

-131.99%-5.76M

-71.12%5.39M

141.19%3.64M

-287.03%-20.32M

-58.70%5.54M

-69.46%18M

-10.77%18.67M

-1,252.22%-8.83M

-193.37%-5.25M

Net PPE purchase and sale

71.32%-39K

-20.30%-160K

22.97%-114K

350.00%90K

--0

-2,620.00%-136K

26.11%-133K

-236.36%-148K

--20K

--0

Net business purchase and sale

----

-119.98%-2.12M

---2.12M

--0

----

--10.59M

--0

----

Net investment purchase and sale

60.28%8.95M

-134.42%-2.57M

-57.16%8.03M

146.93%4.14M

-27.99%-20.32M

-58.37%5.59M

-87.36%7.47M

-10.59%18.74M

-1,250.26%-8.81M

-377.46%-15.88M

Net other investing changes

----

-1,400.00%-910K

---410K

---590K

--0

--90K

--70K

----

Cash from discontinued investing activities

Investing cash flow

60.90%8.91M

-131.99%-5.76M

-71.12%5.39M

141.19%3.64M

-287.03%-20.32M

-58.70%5.54M

-69.46%18M

-10.77%18.67M

-1,252.22%-8.83M

-193.37%-5.25M

Financing cash flow

Cash flow from continuing financing activities

280.00%190K

-79.77%143K

416.67%57K

300.00%10K

-75.93%26K

-91.96%50K

-89.62%707K

-101.82%-18K

-100.11%-5K

-83.93%108K

Net issuance payments of debt

--0

87.76%-6K

--0

---6K

---49K

---18K

---19K

---12K

Net common stock issuance

----

--0

----

--608K

--0

Proceeds from stock option exercised by employees

239.29%190K

0.68%149K

--57K

-28.57%10K

-78.33%26K

300.00%56K

-97.83%148K

--0

-99.70%14K

-82.14%120K

Cash from discontinued financing activities

Financing cash flow

280.00%190K

-79.77%143K

416.67%57K

300.00%10K

-75.93%26K

-91.96%50K

-89.62%707K

-101.82%-18K

-100.11%-5K

-83.93%108K

Net cash flow

Beginning cash position

-53.45%20.75M

-36.06%44.58M

-31.99%21.63M

-51.73%22.65M

-30.86%46.71M

-36.06%44.58M

4.31%69.72M

-48.87%31.81M

-36.63%46.93M

-20.81%67.56M

Current changes in cash

-62.84%751K

5.61%-23.91M

-104.92%-631K

92.45%-1.17M

-17.35%-24.12M

198.30%2.02M

-995.65%-25.33M

71.05%12.81M

-30.81%-15.53M

-82.48%-20.56M

Effect of exchange rate changes

171.93%310K

-56.52%80K

-479.07%-249K

-62.10%155K

176.92%60K

209.62%114K

234.55%184K

-265.38%-43K

1,310.34%409K

---78K

End cash Position

-53.31%21.81M

-53.45%20.75M

-31.99%21.63M

-51.73%22.65M

-30.86%46.71M

-36.06%44.58M

-48.87%31.81M

-36.63%46.93M

Free cash flow

-126.50%-8.39M

58.23%-18.45M

-3.20%-6.1M

28.59%-4.82M

75.17%-3.83M

76.98%-3.71M

30.01%-44.17M

59.11%-5.91M

61.09%-6.75M

12.72%-15.42M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-134.04%-8.35M	58.46%-18.29M	-4.16%-6.08M	28.06%-4.82M	75.17%-3.83M	77.82%-3.57M	30.02%-44.04M	59.53%-5.84M	61.38%-6.7M	12.23%-15.42M
Net income from continuing operations	9.02%-11.15M	39.25%-31.39M	-60.72%-8.89M	32.45%-5.35M	70.50%-4.89M	43.38%-12.25M	42.56%-51.66M	76.35%-5.53M	63.51%-7.92M	23.86%-16.56M
Operating gains losses	----	-143.62%-41K	-300.00%-34K	---8K	---2K	--3K	--94K	--17K	--0	----
Depreciation and amortization	135.29%40K	57.84%322K	623.81%304K	--0	-98.81%1K	-55.26%17K	-40.70%204K	-50.00%42K	-54.02%40K	-3.45%84K
Deferred tax	----	----	----	----	----	----	----	----	----	---284K
Other non cash items	1,282.66%2.93M	632.91%1.67M	6,706.90%1.92M	----	----	---248K	-257.29%-313K	---29K	----	----
Change In working capital	-150.16%-805K	120.11%1.98M	114.15%250K	71.89%-79K	105.13%201K	141.55%1.61M	-130.67%-9.83M	-961.95%-1.77M	92.17%-281K	-31.43%-3.92M
-Change in prepaid assets	-131.14%-440K	64.57%4.25M	972.83%1.97M	-168.58%-443K	-23.77%1.3M	3,264.29%1.41M	411.22%2.58M	27.78%184K	-26.42%646K	156.13%1.71M
-Change in payables and accrued expense	-235.86%-322K	82.07%-2.26M	22.69%-1.52M	131.20%298K	77.32%-1.27M	105.82%237K	-284.59%-12.6M	-3,277.42%-1.97M	78.39%-955K	-3,438.10%-5.61M
-Change in other current assets	---8K	-104.64%-9K	-147.37%-9K	--0	--0	--0	225.16%194K	2,000.00%19K	158.33%28K	83.02%-18K
-Change in other working capital	22.22%-35K	----	----	--66K	--171K	---45K	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-134.04%-8.35M	58.46%-18.29M	-4.16%-6.08M	28.06%-4.82M	75.17%-3.83M	77.82%-3.57M	30.02%-44.04M	59.53%-5.84M	61.38%-6.7M	12.23%-15.42M
Investing cash flow
Cash flow from continuing investing activities	60.90%8.91M	-131.99%-5.76M	-71.12%5.39M	141.19%3.64M	-287.03%-20.32M	-58.70%5.54M	-69.46%18M	-10.77%18.67M	-1,252.22%-8.83M	-193.37%-5.25M
Net PPE purchase and sale	71.32%-39K	-20.30%-160K	22.97%-114K	350.00%90K	--0	-2,620.00%-136K	26.11%-133K	-236.36%-148K	--20K	--0
Net business purchase and sale	----	-119.98%-2.12M	---2.12M	--0	----	----	--10.59M	--0	--0	----
Net investment purchase and sale	60.28%8.95M	-134.42%-2.57M	-57.16%8.03M	146.93%4.14M	-27.99%-20.32M	-58.37%5.59M	-87.36%7.47M	-10.59%18.74M	-1,250.26%-8.81M	-377.46%-15.88M
Net other investing changes	----	-1,400.00%-910K	---410K	---590K	--0	--90K	--70K	----	----	----
Cash from discontinued investing activities
Investing cash flow	60.90%8.91M	-131.99%-5.76M	-71.12%5.39M	141.19%3.64M	-287.03%-20.32M	-58.70%5.54M	-69.46%18M	-10.77%18.67M	-1,252.22%-8.83M	-193.37%-5.25M
Financing cash flow
Cash flow from continuing financing activities	280.00%190K	-79.77%143K	416.67%57K	300.00%10K	-75.93%26K	-91.96%50K	-89.62%707K	-101.82%-18K	-100.11%-5K	-83.93%108K
Net issuance payments of debt	--0	87.76%-6K	--0	--0	--0	---6K	---49K	---18K	---19K	---12K
Net common stock issuance	----	--0	--0	--0	----	----	--608K	--0	--0	--0
Proceeds from stock option exercised by employees	239.29%190K	0.68%149K	--57K	-28.57%10K	-78.33%26K	300.00%56K	-97.83%148K	--0	-99.70%14K	-82.14%120K
Cash from discontinued financing activities
Financing cash flow	280.00%190K	-79.77%143K	416.67%57K	300.00%10K	-75.93%26K	-91.96%50K	-89.62%707K	-101.82%-18K	-100.11%-5K	-83.93%108K
Net cash flow
Beginning cash position	-53.45%20.75M	-36.06%44.58M	-31.99%21.63M	-51.73%22.65M	-30.86%46.71M	-36.06%44.58M	4.31%69.72M	-48.87%31.81M	-36.63%46.93M	-20.81%67.56M
Current changes in cash	-62.84%751K	5.61%-23.91M	-104.92%-631K	92.45%-1.17M	-17.35%-24.12M	198.30%2.02M	-995.65%-25.33M	71.05%12.81M	-30.81%-15.53M	-82.48%-20.56M
Effect of exchange rate changes	171.93%310K	-56.52%80K	-479.07%-249K	-62.10%155K	176.92%60K	209.62%114K	234.55%184K	-265.38%-43K	1,310.34%409K	---78K
End cash Position	-53.31%21.81M	-53.45%20.75M	-53.45%20.75M	-31.99%21.63M	-51.73%22.65M	-30.86%46.71M	-36.06%44.58M	-36.06%44.58M	-48.87%31.81M	-36.63%46.93M
Free cash flow	-126.50%-8.39M	58.23%-18.45M	-3.20%-6.1M	28.59%-4.82M	75.17%-3.83M	76.98%-3.71M	30.01%-44.17M	59.11%-5.91M	61.09%-6.75M	12.72%-15.42M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall